Drugs / DA-4001C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02280603 | Jan → Dec 2014 | androgenetic alopecia | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-4001C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280603 ↗ |
| Route | Topical | “1ml by topical application twice a day” NCT02280603 ↗ |